≡ Risteys
R8

Documentation Changelog GitHub Contact & Feedback

Heart failure and hypertrophic cardiomyopathy

PheWeb

I9_HEARTFAIL_AND_HYPERTCARDIOM

No definition available.

Endpoint definition

↥
FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector
diagram bullet

Check conditions

I9_HYPERTROCARDMYOP

970

diagram downward connector

Filter registries None

0

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

0

diagram downward connector

Check minimum number of events None

0

diagram downward connector
diagram bullet diagram downward connector

Include endpoints

398

diagram downward connector
I9_HEARTFAIL_AND_HYPERTCARDIOM

Extra metadata

First used in FinnGen datafreeze DF5

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 398 134 264
Unadjusted prevalence (%) 0.11 0.07 0.17
Mean age at first event (years) 59.67 60.93 59.04

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: I9_HEARTFAIL_AND_HYPERTCARDIOM – Heart failure and hypertrophic cardiomyopathy
GWS hits: 4

Survival analyses between endpoints

↥

Plot

before Heart failure and hypertrophic cardiomyopathy
after Heart failure and hypertrophic cardiomyopathy

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Heart failure and hypertrophic cardiomyopathy

↥